$MEDCL #Medincell SA MEDINCELL: A critical second part of the year | BUY | EUR11.8 vs. 10.8: MEDINCELL - BUY | EUR11.8 vs. 10.8 A critical second part of the year Costs under strict control in the second half of the year Mdc-IRM to… https://t.co/EjwbBqG0o1 #equity #stocks https://t.co/k3IBk0Uw0m